OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review
Reinaldo B. Bestetti, Rosemary Furlan-Daniel, Vinícius Magalhães Rodrigues Silva
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 7212-7212
Open Access | Times Cited: 13
Reinaldo B. Bestetti, Rosemary Furlan-Daniel, Vinícius Magalhães Rodrigues Silva
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 7212-7212
Open Access | Times Cited: 13
Showing 13 citing articles:
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5795-5795
Open Access | Times Cited: 164
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5795-5795
Open Access | Times Cited: 164
A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Medicine (2023) Vol. 102, Iss. 8, pp. e33024-e33024
Open Access | Times Cited: 37
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Medicine (2023) Vol. 102, Iss. 8, pp. e33024-e33024
Open Access | Times Cited: 37
Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials
Kleyton Santos de Medeiros, Ana Paula Ferreira Costa, Ayane Cristine Alves Sarmento, et al.
BMJ Open (2022) Vol. 12, Iss. 2, pp. e050278-e050278
Open Access | Times Cited: 28
Kleyton Santos de Medeiros, Ana Paula Ferreira Costa, Ayane Cristine Alves Sarmento, et al.
BMJ Open (2022) Vol. 12, Iss. 2, pp. e050278-e050278
Open Access | Times Cited: 28
Subacute hemorrhagic pericardial tamponade after COVID-19 infection mimicking carcinomatous pericarditis: a case report
Hiroyuki Yamamoto, Nao Kume, Katsuya Hashimoto, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 2
Hiroyuki Yamamoto, Nao Kume, Katsuya Hashimoto, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 2
Effectiveness of Molnupiravir Treatment in Patients with COVID-19 in Korea: A Propensity Score Matched Study
Hye Rim Park, Min‐Gyu Yoo, Jong-Mu Kim, et al.
Infection and Chemotherapy (2023) Vol. 55, Iss. 4, pp. 490-490
Open Access | Times Cited: 4
Hye Rim Park, Min‐Gyu Yoo, Jong-Mu Kim, et al.
Infection and Chemotherapy (2023) Vol. 55, Iss. 4, pp. 490-490
Open Access | Times Cited: 4
Trends and Prospects of Nano-delivered Phytopharmaceuticals for disease of Public health importance: A Review
Tolulope O. Ajala, Omobolanle A. Omoteso, Yusuf Oluwagbenga Ghazali
(2024) Vol. 8, Iss. 1
Open Access
Tolulope O. Ajala, Omobolanle A. Omoteso, Yusuf Oluwagbenga Ghazali
(2024) Vol. 8, Iss. 1
Open Access
Impact of COVID-19 on asthma control in Kirkuk City: an analysis of post-pandemic trends
Bilal Jamal Kamal, Mohammed Ali Khalaf
Journal of Medicine and Life (2024) Vol. 17, Iss. 3, pp. 292-295
Open Access
Bilal Jamal Kamal, Mohammed Ali Khalaf
Journal of Medicine and Life (2024) Vol. 17, Iss. 3, pp. 292-295
Open Access
A Phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
Brandon Iturbe Esquivel, José Meneses Calderón, Luis Edgar Concepción-Carrillo, et al.
Monaldi Archives for Chest Disease (2022)
Open Access | Times Cited: 1
Brandon Iturbe Esquivel, José Meneses Calderón, Luis Edgar Concepción-Carrillo, et al.
Monaldi Archives for Chest Disease (2022)
Open Access | Times Cited: 1
The COVID-19 Impact on Oral Healthcare Demand and Performance: The Experience of a Clinical and Academic Centre in Portugal (EU)
João Mendes de Abreu, Ivan Cabo, Maria Inês Borges, et al.
Acta Médica Portuguesa (2022) Vol. 36, Iss. 1, pp. 15-24
Open Access | Times Cited: 1
João Mendes de Abreu, Ivan Cabo, Maria Inês Borges, et al.
Acta Médica Portuguesa (2022) Vol. 36, Iss. 1, pp. 15-24
Open Access | Times Cited: 1
Providing Expert Consultation in a World Living with COVID-19
Jenny Lloyd
EMJ Microbiology & Infectious Diseases (2023), pp. 38-47
Open Access
Jenny Lloyd
EMJ Microbiology & Infectious Diseases (2023), pp. 38-47
Open Access
Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 – A multicenter retrospective observation study
James P. d’Etienne, Naomi Alanis, Eric Chou, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 57-62
Open Access
James P. d’Etienne, Naomi Alanis, Eric Chou, et al.
The American Journal of Emergency Medicine (2022) Vol. 56, pp. 57-62
Open Access
Molnupiravir, a New Antiviral Drug for the Treatment of COVID-19
Ali SARIDAŞ
Eurasian Journal of Critical Care (2022) Vol. 4, Iss. 3, pp. 116-118
Open Access
Ali SARIDAŞ
Eurasian Journal of Critical Care (2022) Vol. 4, Iss. 3, pp. 116-118
Open Access
